Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SPGI vs GSK✓SelectedUSD · GSKSPGI vs GSK performance historyLatest closeAs of-0.42%11/16
Stock and ETF performance explorer

SPGI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+10.6%
GSK return
+46.9%
Excess return
-36.3%
Maximum drawdown
-39.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.4%-0.1%-0.3%-0.4%
7D+0.1%-1.3%+1.4%+0.3%
30D+9.8%+2.7%+7.0%+9.2%
3M+12.9%+2.7%+10.1%+12.2%
6M+24.2%+3.3%+20.9%+23.1%
YTD-4.0%+6.5%-10.4%-6.0%
1Y+1.8%+10.7%-8.8%-1.2%
3Y+26.4%+64.4%-37.9%+8.5%
5Y+10.6%+46.7%-36.1%-8.1%
All+10.6%+46.9%-36.3%-8.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling